Compare SNDA & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNDA | CTKB |
|---|---|---|
| Founded | 1990 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 608.0M | 652.1M |
| IPO Year | 1997 | 2021 |
| Metric | SNDA | CTKB |
|---|---|---|
| Price | $32.49 | $5.03 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 4 |
| Target Price | ★ $28.00 | $5.88 |
| AVG Volume (30 Days) | 51.2K | ★ 1.2M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $327,007,000.00 | $196,828,000.00 |
| Revenue This Year | $27.08 | N/A |
| Revenue Next Year | $4.82 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 29.15 | N/A |
| 52 Week Low | $19.34 | $2.37 |
| 52 Week High | $33.50 | $7.30 |
| Indicator | SNDA | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 52.04 |
| Support Level | $31.43 | $4.95 |
| Resistance Level | $32.82 | $5.13 |
| Average True Range (ATR) | 0.83 | 0.20 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 76.94 | 75.20 |
Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.